Specialist diagnostics partner in the Benelux
+31 (0)85 0045479 Mon–Fri 08:30–17:00 · -
Dengue NS1 Rapid Test – EZER™ Antigen Assay
Rapid Tests
Genesis Distributed by Goffin Diagnostics

Dengue IgG IgM Rapid Test – EZER™ Antigen Assay

The EZER™ Dengue IgG/IgM Rapid Test is a qualitative lateral flow immunoassay designed to detect Dengue IgG IgM antibodies in human whole blood, serum, or plasma. It is intended for rapid differentiation between primary and secondary Dengue virus infections, particularly during the early stages of clinical presentation. By detecting IgM antibodies (indicative of primary infection) and IgG antibodies (associated with secondary or past infection), this test provides important diagnostic insights for managing dengue cases. The dual-marker approach supports timely treatment decisions, especially in endemic regions where multiple serotypes circulate. The test delivers results within 10 minutes, using only 10 µL of sample and 2 drops of buffer. A clear band appears in designated zones for IgG (G), IgM (M), and control (C). With an overall accuracy of 99.4%, the EZER™ Dengue IgG/IgM Rapid Test offers high confidence in serological screening, whether in centralized labs or field settings. This diagnostic solution is manufactured by Genesis Biotech and validated against commercial ELISA methods, showing sensitivity >97% and specificity 100% for both IgM and IgG.

LFA Genesis 1 Package (20 Tests)
Technique
LFA
Brand
Genesis
Packaging
1 Package (20 Tests)
Download documentation

Quote-based, no public pricing. Add to your quote and our specialists put together a proposal with the right documentation, typically within 24 hours.

Product details

This kit in detail

  • Dengue IgG IgM-targeted – Differentiates primary vs. secondary infection
  • Fast results – Clear visual output in just 10 minutes
  • Minimal sample volume – Requires only 10 µL of blood or serum
  • High accuracy – 99.4% overall agreement with commercial ELISA

What is in the Dengue IgG IgM Rapid Test?

Each kit includes:

  • 20 test cassettes with G, M, and C lines

  • 20 calibrated plastic droppers (10 µL)

  • 1 buffer solution tube

  • 1 instruction leaflet (package insert)

The test identifies the presence of IgM (M line) and IgG (G line) antibodies. The control (C line) confirms proper sample migration. This allows for rapid distinction between ongoing and past Dengue infections.

Role of Dengue IgG IgM in Disease

Dengue IgG IgM antibodies represent the body’s immune response to Dengue virus infection:

  • IgM-positive: Typically indicates a recent or primary dengue infection, often in the first 5–7 days post-exposure.

  • IgG-positive: Often indicates a secondary infection or past exposure. Levels tend to rise quickly during reinfection.

  • Both IgG & IgM-positive: Suggest a recent secondary dengue infection, usually associated with more severe clinical outcomes.

By detecting both antibody classes, this rapid test supports better triage and patient risk stratification in outbreak and endemic scenarios.

About the EZER™ Dengue IgG/IgM Rapid Test

This test uses dengue-specific antigens immobilized on a nitrocellulose membrane, designed for antibody capture. During testing:

  1. The patient sample is applied to the sample well

  2. Capillary action draws the sample across the membrane

  3. If Dengue-specific IgG and/or IgM antibodies are present, they bind to colored antigen particles and form visible lines at the G and/or M test regions

Performance Overview:

  • IgM Sensitivity: 97.1%

  • IgG Sensitivity: >99.0%

  • Specificity: 100%

  • Overall Accuracy: 99.4%

Sample Types:

  • Whole blood (EDTA, citrate, or heparin)

  • Serum

  • Plasma

No cross-reactivity was observed with other flaviviruses or infectious markers, ensuring high diagnostic reliability.

Principle and Workflow

Test Procedure:

  1. Allow test and sample to reach room temperature (15–30°C)

  2. Add 10 µL of specimen using the provided dropper

  3. Add 2 drops of buffer

  4. Wait 10 minutes before reading results

Result Interpretation:

  • IgM positive: Band in region M + C

  • IgG positive: Band in region G + C

  • IgG & IgM positive: Bands in G, M, and C regions

  • Negative: Only control line (C) visible

  • Invalid: No C line – retest required

Results beyond 20 minutes should not be interpreted due to possible false positives.

Clinical Application

The EZER™ Dengue IgG/IgM Rapid Test is a reliable frontline tool for:

  • Differential diagnosis during acute febrile illness

  • Epidemiological surveillance in dengue-endemic areas

  • Triage decision-making in emergency care

  • Outbreak management and seroprevalence screening

This test supports rapid response in healthcare settings with limited resources and can complement NS1 antigen testing to capture a broader diagnostic window.

Documentation

Datasheets and regulatory documentation

Everything your quality team needs for evaluation and procurement.

Product Catalogus

PDF Product brochure Dengue IgG IgM Rapid TestPDF · download PDF  IFU Dengue IgG IgM Rapid TestPDF · download
Let’s talk diagnostics

Add this kit to your quote

Tell us the platforms and throughput you’re planning for and our specialists will put together a clear proposal with the right documentation, no public pricing, just a considered answer.

Review my quote Contact a specialist